Profiles Header - Harvard Catalyst Profiles Header – Harvard Catalyst

Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mercedes Corina Becerra, Sc.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring
A Systematic Review of National Policies on Tuberculosis Contact Investigations
Summer, 04/01/15 - 08/01/15
Establishing a Library of Continuing Professional Education at the Centro de Capacitación e Investigación (Center for Training and Research), San Borja, Lima, Peru
International/Summer, 06/23/03 - 08/25/03

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. U19AI076217 (MURRAY, MEGAN B) Sep 30, 2007 - Aug 31, 2014
    NIH/NIAID
    Epidemiology and transmission dynamics of MDR/XDR tuberculosis
    Role: Co-Principal Investigator
  2. U01AI057786 (BECERRA, MERCEDES C) Aug 1, 2006 - Jul 31, 2012
    NIH/NIAID
    Epidemiology of multidrug-resistant tuberculosis in Peru
    Role: Principal Investigator
  3. R01AI057786 (BECERRA, MERCEDES C) Aug 1, 2006 - Jul 31, 2011
    NIH/NIAID
    Epidemiology of multidrug-resistant tuberculosis in Peru
    Role: Principal Investigator
  4. K01HL080939 (BECERRA, MERCEDES C) Sep 26, 2005 - Jul 31, 2012
    NIH/NHLBI
    Molecular epidemiology of drug-resistant tuberculosis in Peru
    Role: Principal Investigator
  5. F31AI010185 (BECERRA, MERCEDES C) Mar 27, 1999
    NIH/NIAID
    MINORITY PREDOCTORAL FELLOWSHIP PROGRAM--NIGMS
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Rodriguez CA, Sasse S, Yuengling KA, Azzawi S, Becerra MC, Yuen CM. A systematic review of national policies for the management of persons exposed to tuberculosis. Int J Tuberc Lung Dis. 2017 08 01; 21(8):935-940. PMID: 28786803.
    View in: PubMed
  2. Velásquez GE, Calderon RI, Mitnick CD, Becerra MC, Huang CC, Zhang Z, Contreras CC, Yataco RM, Galea JT, Lecca LW, Murray MB. Erratum for Velásquez et al., Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis. Antimicrob Agents Chemother. 2017 Mar; 61(3). PMID: 28232308.
    View in: PubMed
  3. Jenkins HE, Yuen CM, Rodriguez CA, Nathavitharana RR, McLaughlin MM, Donald P, Marais BJ, Becerra MC. Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2017 03; 17(3):285-295. PMID: 27964822.
    View in: PubMed
  4. Velásquez GE, Calderon RI, Mitnick CD, Becerra MC, Huang CC, Zhang Z, Contreras CC, Yataco RM, Galea JT, Lecca LW, Murray MB. Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis. Antimicrob Agents Chemother. 2016 11; 60(11):6766-6773. PMID: 27600032.
    View in: PubMed
  5. Mitnick CD, White RA, Lu C, Rodriguez CA, Bayona J, Becerra MC, Burgos M, Centis R, Cohen T, Cox H, D'Ambrosio L, Danilovitz M, Falzon D, Gelmanova IY, Gler MT, Grinsdale JA, Holtz TH, Keshavjee S, Leimane V, Menzies D, Migliori GB, Milstein MB, Mishustin SP, Pagano M, Quelapio MI, Shean K, Shin SS, Tolman AW, van der Walt ML, Van Deun A, Viiklepp P. Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method. Eur Respir J. 2016 10; 48(4):1160-1170. PMID: 27587552.
    View in: PubMed
  6. Chiang SS, Starke JR, Miller AC, Cruz AT, Del Castillo H, Valdivia WJ, Tunque G, García F, Contreras C, Lecca L, Alarcón VA, Becerra MC. Baseline Predictors of Treatment Outcomes in Children With Multidrug-Resistant Tuberculosis: A Retrospective Cohort Study. Clin Infect Dis. 2016 10 15; 63(8):1063-71. PMID: 27458026.
    View in: PubMed
  7. Yuen CM, Jenkins HE, Chang R, Mpunga J, Becerra MC. Two methods for setting child-focused tuberculosis care targets. Public Health Action. 2016 Jun 21; 6(2):83-96. PMID: 27358801; PMCID: PMC4913690.
  8. Ahmad Khan F, Gelmanova IY, Franke MF, Atwood S, Zemlyanaya NA, Unakova IA, Andreev YG, Berezina VI, Pavlova VE, Shin SS, Yedilbayev AB, Becerra MC, Keshavjee S. Aggressive Regimens Reduce Risk of Recurrence After Successful Treatment of MDR-TB. Clin Infect Dis. 2016 07 15; 63(2):214-20. PMID: 27161772.
    View in: PubMed
  9. Yuen CM, Amanullah F, Dharmadhikari A, Nardell EA, Seddon JA, Vasilyeva I, Zhao Y, Keshavjee S, Becerra MC. Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment. Lancet. 2015 Dec 05; 386(10010):2334-43. PMID: 26515675.
    View in: PubMed
  10. Chiang SS, Roche S, Contreras C, Alarcón V, Del Castillo H, Becerra MC, Lecca L. Barriers to the diagnosis of childhood tuberculosis: a qualitative study. Int J Tuberc Lung Dis. 2015 Oct; 19(10):1144-52. PMID: 26459524.
    View in: PubMed
  11. Salvatore PP, Becerra MC, Abel zur Wiesch P, Hinkley T, Kaur D, Sloutsky A, Cohen T. Fitness Costs of Drug Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis: A Household-Based Case-Control Study. J Infect Dis. 2016 Jan 01; 213(1):149-55. PMID: 26092854; PMCID: PMC4676541 [Available on 01/01/17].
  12. Yuen CM, Jenkins HE, Rodriguez CA, Keshavjee S, Becerra MC. Global and Regional Burden of Isoniazid-Resistant Tuberculosis. Pediatrics. 2015 Jul; 136(1):e50-9. PMID: 26034243; PMCID: PMC4485010.
  13. Nachman S, Ahmed A, Amanullah F, Becerra MC, Botgros R, Brigden G, Browning R, Gardiner E, Hafner R, Hesseling A, How C, Jean-Philippe P, Lessem E, Makhene M, Mbelle N, Marais B, McIlleron H, McNeeley DF, Mendel C, Murray S, Navarro E, Anyalechi EG, Porcalla AR, Powell C, Powell M, Rigaud M, Rouzier V, Samson P, Schaaf HS, Shah S, Starke J, Swaminathan S, Wobudeya E, Worrell C. Towards early inclusion of children in tuberculosis drugs trials: a consensus statement. Lancet Infect Dis. 2015 Jun; 15(6):711-20. PMID: 25957923; PMCID: PMC4471052.
  14. Franke MF, Becerra MC, Tierney DB, Rich ML, Bonilla C, Bayona J, McLaughlin MM, Mitnick CD. Counting pyrazinamide in regimens for multidrug-resistant tuberculosis. Ann Am Thorac Soc. 2015 May; 12(5):674-9. PMID: 25664920; PMCID: PMC4418338.
  15. Yuen CM, Rodriguez CA, Keshavjee S, Becerra MC. Map the gap: missing children with drug-resistant tuberculosis. Public Health Action. 2015 Mar 21; 5(1):45-58. PMID: 26400601; PMCID: PMC4525371.
  16. Kurbatova EV, Cegielski JP, Lienhardt C, Akksilp R, Bayona J, Becerra MC, Caoili J, Contreras C, Dalton T, Danilovits M, Demikhova OV, Ershova J, Gammino VM, Gelmanova I, Heilig CM, Jou R, Kazennyy B, Keshavjee S, Kim HJ, Kliiman K, Kvasnovsky C, Leimane V, Mitnick CD, Quelapio I, Riekstina V, Smith SE, Tupasi T, van der Walt M, Vasilyeva IA, Via LE, Viiklepp P, Volchenkov G, Walker AT, Wolfgang M, Yagui M, Zignol M. Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies. Lancet Respir Med. 2015 Mar; 3(3):201-9. PMID: 25726085; PMCID: PMC4401426.
  17. Huang CC, Tchetgen ET, Becerra MC, Cohen T, Galea J, Calderon R, Yataco R, Contreras C, Zhang ZB, Lecca L, Murray M. Cigarette smoking among tuberculosis patients increases risk of transmission to child contacts. Int J Tuberc Lung Dis. 2014 Nov; 18(11):1285-91. PMID: 25299859.
    View in: PubMed
  18. Jenkins HE, Pagano M, Yuen CM, Becerra MC, Cohen T. The burden of tuberculosis disease in children--Authors' reply. Lancet. 2014 Oct 11; 384(9951):1343-4. PMID: 25307837.
    View in: PubMed
  19. Tierney DB, Franke MF, Becerra MC, Alcántara Virú FA, Bonilla CA, Sánchez E, Guerra D, Muñoz M, Llaro K, Palacios E, Mestanza L, Hurtado RM, Furin JJ, Shin S, Mitnick CD. Time to culture conversion and regimen composition in multidrug-resistant tuberculosis treatment. PLoS One. 2014; 9(9):e108035. PMID: 25238411; PMCID: PMC4169600.
  20. Becerra MC, Swaminathan S. Commentary: a targets framework: dismantling the invisibility trap for children with drug-resistant tuberculosis. J Public Health Policy. 2014 Nov; 35(4):425-54. PMID: 25209537.
    View in: PubMed
  21. Zelner JL, Murray MB, Becerra MC, Galea J, Lecca L, Calderon R, Yataco R, Contreras C, Zhang Z, Grenfell BT, Cohen T. Age-specific risks of tuberculosis infection from household and community exposures and opportunities for interventions in a high-burden setting. Am J Epidemiol. 2014 Oct 15; 180(8):853-61. PMID: 25190676; PMCID: PMC4188339.
  22. Chiang SS, Cruz AT, Del Castillo H, Contreras C, Becerra MC, Lecca L. Evaluation of health-care providers' knowledge of childhood tuberculosis in Lima, Peru. Paediatr Int Child Health. 2015 Feb; 35(1):29-35. PMID: 25161060.
    View in: PubMed
  23. Chiang SS, Khan FA, Milstein MB, Tolman AW, Benedetti A, Starke JR, Becerra MC. Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2014 Oct; 14(10):947-57. PMID: 25108337.
    View in: PubMed
  24. Velásquez GE, Becerra MC, Gelmanova IY, Pasechnikov AD, Yedilbayev A, Shin SS, Andreev YG, Yanova G, Atwood SS, Mitnick CD, Franke MF, Rich ML, Keshavjee S. Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death. Clin Infect Dis. 2014 Jul 01; 59(1):9-15. PMID: 24729493; PMCID: PMC4305127.
  25. Zelner JL, Murray MB, Becerra MC, Galea J, Lecca L, Calderon R, Yataco R, Contreras C, Zhang Z, Grenfell BT, Cohen T. Bacillus Calmette-Guérin and isoniazid preventive therapy protect contacts of patients with tuberculosis. Am J Respir Crit Care Med. 2014 Apr 01; 189(7):853-9. PMID: 24592878; PMCID: PMC4225829.
  26. Jenkins HE, Tolman AW, Yuen CM, Parr JB, Keshavjee S, Pérez-Vélez CM, Pagano M, Becerra MC, Cohen T. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet. 2014 May 03; 383(9928):1572-9. PMID: 24671080; PMCID: PMC4094366.
  27. Franke MF, del Castillo H, Pereda Y, Lecca L, Cárdenas L, Fuertes J, Murray MB, Bayona J, Becerra MC. Modifiable factors associated with tuberculosis disease in children: a case-control study. Pediatr Infect Dis J. 2014 Jan; 33(1):109-11. PMID: 24064556.
    View in: PubMed
  28. Franke MF, Del Castillo H, Pereda Y, Lecca L, Fuertes J, Cárdenas L, Becerra MC, Bayona J, Murray M. Parasite infection and tuberculosis disease among children: a case-control study. Am J Trop Med Hyg. 2014 Feb; 90(2):279-82. PMID: 24379242; PMCID: PMC3919232.
  29. Huang CC, Tchetgen ET, Becerra MC, Cohen T, Hughes KC, Zhang Z, Calderon R, Yataco R, Contreras C, Galea J, Lecca L, Murray M. The effect of HIV-related immunosuppression on the risk of tuberculosis transmission to household contacts. Clin Infect Dis. 2014 Mar; 58(6):765-74. PMID: 24368620; PMCID: PMC3935504.
  30. Parr JB, Mitnick CD, Atwood SS, Chalco K, Bayona J, Becerra MC. Concordance of resistance profiles in households of patients with multidrug-resistant tuberculosis. Clin Infect Dis. 2014 Feb; 58(3):392-5. PMID: 24170196; PMCID: PMC3890336.
  31. Shah NS, Yuen CM, Heo M, Tolman AW, Becerra MC. Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis. Clin Infect Dis. 2014 Feb; 58(3):381-91. PMID: 24065336; PMCID: PMC3890332.
  32. Stagg HR, Cohen T, Becerra MC, Anderson LF, Abubakar I. A tale of two settings: the role of the Beijing genotype in the epidemiology of multidrug-resistant tuberculosis. Eur Respir J. 2014 Feb; 43(2):632-5. PMID: 24036242.
    View in: PubMed
  33. Seung KJ, Becerra MC, Atwood SS, Alcántara F, Bonilla CA, Mitnick CD. Salvage therapy for multidrug-resistant tuberculosis. Clin Microbiol Infect. 2014 May; 20(5):441-6. PMID: 23991934.
    View in: PubMed
  34. Yuen CM, Tolman AW, Cohen T, Parr JB, Keshavjee S, Becerra MC. Isoniazid-resistant tuberculosis in children: a systematic review. Pediatr Infect Dis J. 2013 May; 32(5):e217-26. PMID: 23348808.
    View in: PubMed
  35. Mitnick CD, Franke MF, Rich ML, Alcantara Viru FA, Appleton SC, Atwood SS, Bayona JN, Bonilla CA, Chalco K, Fraser HS, Furin JJ, Guerra D, Hurtado RM, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Seung KJ, Shin SS, Sloutsky A, Tolman AW, Becerra MC. Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality. PLoS One. 2013; 8(3):e58664. PMID: 23516529; PMCID: PMC3596279.
  36. Becerra MC, Franke MF, Appleton SC, Joseph JK, Bayona J, Atwood SS, Mitnick CD. Tuberculosis in children exposed at home to multidrug-resistant tuberculosis. Pediatr Infect Dis J. 2013 Feb; 32(2):115-9. PMID: 22926210.
    View in: PubMed
  37. Satti H, McLaughlin MM, Seung KJ, Becerra MC, Keshavjee S. High risk of drug-resistant tuberculosis when first-line therapy fails in a high HIV prevalence setting. Int J Tuberc Lung Dis. 2013 Jan; 17(1):100-6. PMID: 23232009.
    View in: PubMed
  38. Fraser HS, Habib A, Goodrich M, Thomas D, Blaya JA, Fils-Aime JR, Jazayeri D, Seaton M, Khan AJ, Choi SS, Kerrison F, Falzon D, Becerra MC. E-health systems for management of MDR-TB in resource-poor environments: a decade of experience and recommendations for future work. Stud Health Technol Inform. 2013; 192:627-31. PMID: 23920632.
    View in: PubMed
  39. Franke MF, Appleton SC, Mitnick CD, Furin JJ, Bayona J, Chalco K, Shin S, Murray M, Becerra MC. Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence. Clin Infect Dis. 2013 Mar; 56(6):770-6. PMID: 23223591; PMCID: PMC3582355.
  40. Fraser HS, Thomas D, Tomaylla J, Garcia N, Lecca L, Murray M, Becerra MC. Adaptation of a web-based, open source electronic medical record system platform to support a large study of tuberculosis epidemiology. BMC Med Inform Decis Mak. 2012 Nov 07; 12:125. PMID: 23131180; PMCID: PMC3531253.
  41. Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, Becerra MC, Benedetti A, Burgos M, Centis R, Chan ED, Chiang CY, Cox H, D'Ambrosio L, DeRiemer K, Dung NH, Enarson D, Falzon D, Flanagan K, Flood J, Garcia-Garcia ML, Gandhi N, Granich RM, Hollm-Delgado MG, Holtz TH, Iseman MD, Jarlsberg LG, Keshavjee S, Kim HR, Koh WJ, Lancaster J, Lange C, de Lange WC, Leimane V, Leung CC, Li J, Menzies D, Migliori GB, Mishustin SP, Mitnick CD, Narita M, O'Riordan P, Pai M, Palmero D, Park SK, Pasvol G, Peña J, Pérez-Guzmán C, Quelapio MI, Ponce-de-Leon A, Riekstina V, Robert J, Royce S, Schaaf HS, Seung KJ, Shah L, Shim TS, Shin SS, Shiraishi Y, Sifuentes-Osornio J, Sotgiu G, Strand MJ, Tabarsi P, Tupasi TE, van Altena R, Van der Walt M, Van der Werf TS, Vargas MH, Viiklepp P, Westenhouse J, Yew WW, Yim JJ. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med. 2012; 9(8):e1001300. PMID: 22952439; PMCID: PMC3429397.
  42. Kurbatova EV, Taylor A, Gammino VM, Bayona J, Becerra M, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Viiklepp P, Zignol M, Cegielski JP. Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects. Tuberculosis (Edinb). 2012 Sep; 92(5):397-403. PMID: 22789497; PMCID: PMC4749016.
  43. Khan AJ, Khowaja S, Khan FS, Qazi F, Lotia I, Habib A, Mohammed S, Khan U, Amanullah F, Hussain H, Becerra MC, Creswell J, Keshavjee S. Engaging the private sector to increase tuberculosis case detection: an impact evaluation study. Lancet Infect Dis. 2012 Aug; 12(8):608-16. PMID: 22704778.
    View in: PubMed
  44. Satti H, McLaughlin MM, Omotayo DB, Keshavjee S, Becerra MC, Mukherjee JS, Seung KJ. Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence. PLoS One. 2012; 7(5):e37114. PMID: 22629356; PMCID: PMC3358299.
  45. Furin J, Gegia M, Mitnick C, Rich M, Shin S, Becerra M, Drobac P, Farmer P, Hurtado R, Joseph JK, Keshavjee S, Kalandadze I. Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experience. Bull World Health Organ. 2012 Jan 01; 90(1):63-6. PMID: 22271966; PMCID: PMC3260578.
  46. Furin J, Bayona J, Becerra M, Farmer P, Golubkov A, Hurtado R, Joseph JK, Keshavjee S, Ponomarenko O, Rich M, Shin S. Programmatic management of multidrug-resistant tuberculosis: models from three countries. Int J Tuberc Lung Dis. 2011 Oct; 15(10):1294-300. PMID: 21669029.
    View in: PubMed
  47. Cohen T, Murray M, Abubakar I, Zhang Z, Sloutsky A, Arteaga F, Chalco K, Franke MF, Becerra MC. Multiple introductions of multidrug-resistant tuberculosis into households, Lima, Peru. Emerg Infect Dis. 2011 Jun; 17(6):969-75. PMID: 21749756; PMCID: PMC3358204.
  48. Brooks-Pollock E, Becerra MC, Goldstein E, Cohen T, Murray MB. Epidemiologic inference from the distribution of tuberculosis cases in households in Lima, Peru. J Infect Dis. 2011 Jun 01; 203(11):1582-9. PMID: 21592987; PMCID: PMC3096792.
  49. Becerra MC, Appleton SC, Franke MF, Chalco K, Arteaga F, Bayona J, Murray M, Atwood SS, Mitnick CD. Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study. Lancet. 2011 Jan 08; 377(9760):147-52. PMID: 21145581.
    View in: PubMed
  50. Becerra MC, Appleton SC, Franke MF, Chalco K, Bayona J, Murray MB, Mitnick CD. Recurrence after treatment for pulmonary multidrug-resistant tuberculosis. Clin Infect Dis. 2010 Sep 15; 51(6):709-11. PMID: 20687835.
    View in: PubMed
  51. Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, Furin JJ, Fitzmaurice GM, Alcantara Viru FA, Appleton SC, Bayona JN, Bonilla CA, Chalco K, Choi S, Franke MF, Fraser HS, Guerra D, Hurtado RM, Jazayeri D, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Sloutsky A, Becerra MC. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med. 2008 Aug 07; 359(6):563-74. PMID: 18687637; PMCID: PMC2673722.
  52. Franke MF, Appleton SC, Bayona J, Arteaga F, Palacios E, Llaro K, Shin SS, Becerra MC, Murray MB, Mitnick CD. Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment. Clin Infect Dis. 2008 Jun 15; 46(12):1844-51. PMID: 18462099; PMCID: PMC2577177.
  53. Drobac PC, Mukherjee JS, Joseph JK, Mitnick C, Furin JJ, del Castillo H, Shin SS, Becerra MC. Community-based therapy for children with multidrug-resistant tuberculosis. Pediatrics. 2006 Jun; 117(6):2022-9. PMID: 16740844.
    View in: PubMed
  54. Rich ML, Socci AR, Mitnick CD, Nardell EA, Becerra MC, Bonilla C, Bayona J, Seung KJ, Furin J, Farmer PE, Mukherjee JS. Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB. Int J Tuberc Lung Dis. 2006 Mar; 10(3):290-6. PMID: 16562709.
    View in: PubMed
  55. Becerra MC, Pachao-Torreblanca IF, Bayona J, Celi R, Shin SS, Kim JY, Farmer PE, Murray M. Expanding tuberculosis case detection by screening household contacts. Public Health Rep. 2005 May-Jun; 120(3):271-7. PMID: 16134567; PMCID: PMC1497729.
  56. Timperi R, Han LL, Sloutsky A, Becerra MC, Nardell EA, Salazar JJ, Smith-Fawzi MC. Drug resistance profiles of Mycobacterium tuberculosis isolates: five years' experience and insight into treatment strategies for MDR-TB in Lima, Peru. Int J Tuberc Lung Dis. 2005 Feb; 9(2):175-80. PMID: 15732737.
    View in: PubMed
  57. Shin SS, Naroditskaya V, Sloutsky A, Werner B, Timperi R, Bayona J, Farmer PE, Becerra MC. rpoB gene mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis in northern Lima, Peru. Microb Drug Resist. 2005; 11(1):26-30. PMID: 15770091.
    View in: PubMed
  58. Vásquez-Campos L, Asencios-Solis L, Leo-Hurtado E, Quispe-Torres N, Salazar-Lindo E, Bayona J, Becerra MC. Drug resistance trends among previously treated tuberculosis patients in a national registry in Peru, 1994-2001. Int J Tuberc Lung Dis. 2004 Apr; 8(4):465-72. PMID: 15141740.
    View in: PubMed
  59. Mukherjee JS, Rich ML, Socci AR, Joseph JK, Virú FA, Shin SS, Furin JJ, Becerra MC, Barry DJ, Kim JY, Bayona J, Farmer P, Smith Fawzi MC, Seung KJ. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet. 2004 Feb 07; 363(9407):474-81. PMID: 14962530.
    View in: PubMed
  60. Chavez Pachas AM, Blank R, Smith Fawzi MC, Bayona J, Becerra MC, Mitnick CD. Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru. Int J Tuberc Lung Dis. 2004 Jan; 8(1):52-8. PMID: 14974746.
    View in: PubMed
  61. Cohen T, Becerra MC, Murray MB. Isoniazid resistance and the future of drug-resistant tuberculosis. Microb Drug Resist. 2004; 10(4):280-5. PMID: 15650371; PMCID: PMC2652757.
  62. Bayona J, Chavez-Pachas AM, Palacios E, Llaro K, Sapag R, Becerra MC. Contact investigations as a means of detection and timely treatment of persons with infectious multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2003 Dec; 7(12 Suppl 3):S501-9. PMID: 14677844.
    View in: PubMed
  63. Bayona J, Chavez-Pachas AM, Palacios E, Llaro K, Sapag R, Becerra MC. Contact investigations as a means of detection and timely treatment of persons with infectious multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2003 Dec 01; 7(12):501-509. PMID: 29490867.
    View in: PubMed
  64. Mitnick C, Bayona J, Palacios E, Shin S, Furin J, Alcántara F, Sánchez E, Sarria M, Becerra M, Fawzi MC, Kapiga S, Neuberg D, Maguire JH, Kim JY, Farmer P. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med. 2003 Jan 09; 348(2):119-28. PMID: 12519922.
    View in: PubMed
  65. Kim JY, Mukherjee JS, Rich ML, Mate K, Bayona J, Becerra MC. From multidrug-resistant tuberculosis to DOTS expansion and beyond: making the most of a paradigm shift. Tuberculosis (Edinb). 2003; 83(1-3):59-65. PMID: 12758190.
    View in: PubMed
  66. Farmer P, Bayona J, Becerra M. Multidrug-resistant tuberculosis and the need for biosocial perspectives. Int J Tuberc Lung Dis. 2001 Oct; 5(10):885-6. PMID: 11605879.
    View in: PubMed
  67. Farmer P, Léandre F, Mukherjee JS, Claude M, Nevil P, Smith-Fawzi MC, Koenig SP, Castro A, Becerra MC, Sachs J, Attaran A, Kim JY. Community-based approaches to HIV treatment in resource-poor settings. Lancet. 2001 Aug 04; 358(9279):404-9. PMID: 11502340.
    View in: PubMed
  68. Furin JJ, Mitnick CD, Shin SS, Bayona J, Becerra MC, Singler JM, Alcantara F, Castañieda C, Sanchez E, Acha J, Farmer PE, Kim JY. Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2001 Jul; 5(7):648-55. PMID: 11467371.
    View in: PubMed
  69. Becerra MC, Bayona J, Freeman J, Farmer PE, Kim JY. Redefining MDR-TB transmission 'hot spots'. Int J Tuberc Lung Dis. 2000 May; 4(5):387-94. PMID: 10815730.
    View in: PubMed
  70. Keshavjee S, Becerra MC. Disintegrating health services and resurgent tuberculosis in post-Soviet Tajikistan: an example of structural violence. JAMA. 2000 Mar 01; 283(9):1201. PMID: 10703788.
    View in: PubMed
  71. Furin JJ, Becerra MC, Shin SS, Kim JY, Bayona J, Farmer PE. Effect of administering short-course, standardized regimens in individuals infected with drug-resistant Mycobacterium tuberculosis strains. Eur J Clin Microbiol Infect Dis. 2000 Feb; 19(2):132-6. PMID: 10746502.
    View in: PubMed
  72. Becerra MC, Freeman J, Bayona J, Shin SS, Kim JY, Furin JJ, Werner B, Sloutsky A, Timperi R, Wilson ME, Pagano M, Farmer PE. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2000 Feb; 4(2):108-14. PMID: 10694087.
    View in: PubMed
  73. Farmer P, Furin J, Bayona J, Becerra M, Henry C, Hiatt H, Kim JY, Mitnick C, Nardell E, Shin S. Management of MDR-TB in resource-poor countries. Int J Tuberc Lung Dis. 1999 Aug; 3(8):643-5. PMID: 10460095.
    View in: PubMed
  74. Farmer P, Bayona J, Becerra M, Furin J, Henry C, Hiatt H, Kim JY, Mitnick C, Nardell E, Shin S. The dilemma of MDR-TB in the global era. Int J Tuberc Lung Dis. 1998 Nov; 2(11):869-76. PMID: 9848606.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Becerra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (231)
Explore
_
Co-Authors (33)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Tool Page Footer - Harvard Catalyst Tool Page Footer – Harvard Catalyst
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.